Karyopharm Therapeutics Incis A Pharmaceutical Company Founded In 2008Dedicated To Discovering And Developing Innovative Medicines For Cancer And Other Serious Diseasesthe Company Utilizes Sine Technologyselective Inhibition Of Nuclear Exportto Target Specific Proteins In Cancer Cellswhich Is Central To Its Therapeutic Strategies Karyopharm S Lead Productxpovioselinexor Is Approved For Treating Multiple Myeloma And Relapsed Or Refractory Diffuse Large B Cell Lymphomaand Is Available In The Useuukand Israelthe Company Is Also Advancing Several Drug Candidates In Clinical Developmentincluding Selinexoreltanexorand Kpt 9274Aimed At Various Hematological And Solid Tumor Malignancies Headquartered In Newtonmassachusettskaryopharm Operates Additional Facilities In Israel And Germanythe Company Emphasizes A Culture Of Innovation And Integrityled By An Experienced Management Teamkaryopharm S Financial Performance Has Shown Growthwith Revenues Reflecting Its Ongoing Commitment To The Pharmaceutical Sector
No conferences found for this company.
| Company Name | Karyopharm Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
